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Pharmaceutical dosage formAbstract A Simple and rapid reversed-phase high-performance liquid chromatographic method
for the direct determination of pantoprazole in pharmaceutical dosage forms was developed and
validated. Lansoprazole was used as internal standard. The chromatographic separation of pantop-
razole and lansoprazole was achieved on a Nucleodur C8 column (250 · 4.6 mm i.d., 5 lm particle
size) using the photodiode array detector at 280 nm. The optimized mobile phase was consisted of a
mixture of 0.1 M ammonium acetate solution and methanol (42:58, v/v), pumped at a ﬂow rate
1.0 mL min1. The retention times for pantoprazole and lansoprazole were 8.10 and 11.15 min,
respectively. Linearity range was 3.06–1243.0 lg mL1 with limit of detection value of
0.78 lg mL1. The precision of the method was demonstrated using intra- and inter-day assay
RSD% values which were less than 2.07%, while the recovery was 99.07–103.95%. No interference
from any components of pharmaceutical dosage forms or degradation products was observed.
According to the validation results, the proposed method was found to be speciﬁc, accurate, precise
and could be applied to the quantitative analysis of pantoprazole in tablets.
ª 2011 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Pantoprazole, 5-diﬂuoromethoxybenzimidazole-2-yl 3,4-dime-
thoxy-2-pyridylmethyl sulfoxide (CAS, 102625-70-7; MW,
383.4) is an irreversible proton pump (H+/K+-ATPase) inhib-
itor (PPI) that decreases acid secretion from gastric parietal
cells (Cheer et al., 2003). It is also effective in Zollinger–Ellison
syndrome and in preventing ulcer rebleeding. Thus pantopraz-
ole is a valuable alternate to other PPIs in the treatment of
acid-related disorders. The drug is ofﬁcially listed in Martin-
dale the extra pharmacopoeia ( 2005). A literature survey
Table 1 Calibration data for the estimation of pantoprazole
by HPLC.
Parameters Pantoprazole
Optimum concentration range (lg mL1) 3.06–1243.0
Regression equation for the peak area of PPZ vs. concentration of
PPZ in lg/mL, APPZ = 0.762CPPZ + 5.578
Correlation coeﬃcient (r2) 0.9999
Standard deviation of slope 0.0019
Standard deviation of intercept 0.7711
Regression equation for the ratio of peak area of PPZ to that of I.S.
(LPZ) vs. concentration of PPZ in lg/mL, RPPZ/
LPZ = 0.008CPPZ + 0.060
Correlation coeﬃcient (r2) 0.9999
Standard deviation of slope 0.0018
Standard deviation of intercept 0.0033
Limit of quantiﬁcation, LOQ (lg mL1) 2.60
Limit of detection, LOD (lg mL1) 0.78
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Rajic et al., 2003; Salama et al., 2003; Moustafa, 2000; Syed
and Syeda, 2008), kinetic spectrophotometric (Rahman and
Kashif, 2005; Rahman et al., 2006), capillary zone electropho-
resis (Eberle et al., 1997; Tivesten et al., 1999) and voltammet-
ric (Radi, 2003; Chung et al., 2003; Erk, 2003) methods for the
determination of pantoprazole in drug formulations have been
described. In the literature only a few high-performance liquid
chromatographic methods for the determination of pantopraz-
ole in pharmaceutical formulations have been reported (Man-
sour and Sorour, 2001; Tanaka et al., 1995). An increasing
number of publications are appearing describing the develop-
ment of methods for pantoprazole determination in biological
samples (Tanaka and Yamazaki, 1996; Ramakrishna et al.,
2005; Storms and Stewart, 2002; Cass et al., 2002).
The objective of this work was to develop an analytical LC
procedure, which would serve as reliable and rapid method for
the determination of pantoprazole in pharmaceutical prepara-
tions. This manuscript describes the development and subse-
quent validation of isocratic reversed-phase HPLC method
using C8 column as stationary phase for the above determina-
tion. In the proposed LC method, pantoprazole and lansop-
razole (internal standard) were well separated and eluted
before 12 min run time. The precision of the described method
for assay of pantoprazole has been checked in terms of F-test
using a reported method as reference.
2. Experimental
2.1. Chromatographic system
Chromatographic analysis was performed on a modular HPLC
system, Hitachi (Japan) consisted of binary pump (L-2130, ﬂow
rate range of 0.000–9.999 mL min1), auto sampler (L-2200,
injection volume of 0.1–100 lL), column oven (L-2350, temper-
ature range of 1–85 C) and ultraviolet detector (L-2455, 190–
850 nm) operated at wavelength of 280 nm and a quartz ﬂow
cell (10 mm path and 17 lL volume). Separation was achieved
on a reversed-phase Nucleodur C8 column (250 · 4.6 mm,
5 lm particle size, Macherey-Nagel Germany). The mobile
phase was a mixture of a 0.1 M ammonium acetate and metha-
nol (42:58, v/v) and was ﬁltered and degassed by ultrasonic agi-
tation before use. The mobile phase was prepared weekly and
was delivered at a ﬂow rate of 1.0 mL min1. Data were moni-
tored and processed using automation system software. Peak
areas were integrated automatically by computer using the Ez-
chrom Elite Hitachi software program. The injection volume
was 10 lL. The system was operated at ambient temperature.
2.2. Chemicals
HPLC grade methanol and water were purchased from Merck
(Darmstadt, Germany). Analytical reagent grade ammonium
acetate from Merck (Darmstadt, Germany) and acetic acid
glacial from SCP (England) were used to prepare the mobile
phase.
2.3. Materials
Pantoprazole sodium (C16H35F2N3NaO4S = 426.52 g/mol, its
purity was found to be 100.66% according to the compendialmethod) and the internal standard (lansoprazole USP,
C16H14F3N3O2S = 369.37 g/mol, its purity was found to be
99.5%) were obtained from SL Drugs & Pharmaceuticals, In-
dia. Tablets containing pantoprazole sodium: Penta 40 mg (Al-
pha, Syria), Progast 40 mg (K.C. pharma, Syria) and
Pantoprazol 40 mg (Amrit Medical Co., Syria).
2.4. Standard solutions
Standard solution of pantoprazole sodium (PPZ) was prepared
by direct weighing of standard substance with subsequent dis-
solution in methanol. The concentration of the stock standard
solution was 2.0 mg mL1. Stock standard solution of lansop-
razole (LPZ) 1.0 mg mL1 was prepared by dissolving appro-
priate amount of the compound in methanol. These
solutions were stored in the dark at 2–8 C and were found
to be stable for one month at least. A series of working stan-
dard solutions of PPZ (3.06–1243.0 lg mL1) were prepared
by diluting the stock standard solution with the methanol. In
each sample 1 mL of LPZ was added. Standard solutions were
found to be stable during the analysis time.
2.5. Calibration curve
To construct the calibration curve ﬁve replicates (10 lL) of
each standard solution were injected immediately after prepa-
ration into the column and the peak area of the chromato-
grams was measured. Then, the mean peak area ratio of PPZ
to that of the internal standard was plotted against the corre-
sponding concentration of PPZ (3.06–1243.0 lg mL1) to ob-
tain the calibration graph (Table 1).
2.6. Assay procedure for dosage forms
Twenty tablets containing PPZ were weighed and ﬁnely pow-
dered. Five accurately weighed quantities of the powder equiv-
alent to 50 mg of PPZ were transferred into 25 mL separated
volumetric ﬂasks. A 20 mL of methanol was then added to
each ﬂask and the mixture was sonicated for 10 min. Then,
the volume of each mixture was adjusted to 25 mL with meth-
anol. The sample solutions were ﬁltered and a suitable concen-
tration was prepared by diluting 0.5 mL of the ﬁltrates with
Figure 1 Plots of the retention time of PPZ and LPZ vs.
methanol concentration in the mobile phase.
S116 S. Ashour, S. Omarmethanol to 10 mL in volumetric ﬂasks containing 1 mL of the
internal standard LPZ. Finally, 10 lL of each diluted sample
was injected into the column. Peak area ratios of PPZ to that
of LPZ were then measured for the determination. PPZ con-
centrations in the samples were then calculated using peak
data and standard curves.
2.7. Optimization procedure
On the basis of the optimization procedure the following fac-
tors were selected and tested in the experimental design: (A)
volume percent of methanol (50–70%), (B) ﬂow rate range
(0.8–1.3 mL min1) and (C) pH of ammonium acetate solution
(2.5–7.0). Factor levels are given in parenthesis. Experimental
design indicates that the best conditions for separation of pan-
toprazole from internal standard are at mobile phase composi-
tion: (0.1 M) ammonium acetate and methanol (42:58, v/v).
2.8. Validation
The standard curve was a plot of the peak area ratios of PPZ–
LPZ vs. the corresponding concentrations of PPZ in the stan-
dard curve samples. The linearity of the standard curve was
evaluated using least-squares linear regression analysis. To
determine recovery of RPZ at concentrations of 3.06, 10,
100, 200, 400, 800 and 1200 lg mL1 and of LPZ at the con-
centration used in the assay (100 lg mL1) from bulk or for-
mulations, an identical set of standards prepared in the
methanol was analysed. Absolute recoveries at each concentra-
tion were measured by comparing the response of pre-treated
standards with the response of standards which had not been
subjected to sample pre-treatment. Intra- and inter-day coefﬁ-
cients of in variation of the assay were determined by the anal-
ysis of ﬁve samples at each concentration on the same day and
of ﬁve samples at each concentration on three different days,
respectively. The limit of quantiﬁcation for this assay is deﬁned
as the lowest concentration of LPZ that can be detected.Figure 2 A typical chromatogram of a mixture of PPZ (500 lg mL
respectively. Chromatographic conditions: RP-HPLC on C8 column; m
rate 1.0 mL min1 and detection at 280 nm.3. Results and discussion
3.1. Chromatography and selectivity
The goal of this study was to develop HPLC assay for the anal-
ysis of PPZ drug in pharmaceutical dosage form. Initial studies
to develop HPLC assay involved the use of C18 and C8
columns with various mobile phases containing acetonitrile-
or methanol-aqueous ammonium acetate buffers. The C8 col-
umn was chosen for further studies since it produced sharp
and symmetrical peaks. The ﬁnal selective HPLC mobile phase
consisting of MeOH–NH4OAC. The effect of composition of
the mobile phase on the retention time of PPZ and the internal
standard, LPZ, was investigated. Results of the effect of meth-
anol in the mobile phase are presented in Fig. 1. An increase
in the percentage of methanol decreases the retention of1) and LPZ (100 lg mL1) at retention times 8.10 and 11.15 min,
obile phase: 0.1 M ammonium acetate: methanol (42:58, v/v); ﬂow
Figure 3 A typical chromatogram of a mixture of PPZ (500 lg mL1) and the internal standard, LPZ (100 lg mL1) in the mobile
phase, prepared from PENTA 40 mg tablets. Chromatographic conditions: C8 column; mobile phase: 0.1 M ammonium acetate and
methanol (42:58, v/v); ﬂow rate 1.0 mL min1 and detection at 280 nm.
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to more than 70% RPZ peak is eluted with the solvent front,
while at methanol concentration lower than 55% the elution
of LPZ peak is seriously delayed. The optimum methanol con-
centration was found to be 58%.
The effect of pH in the chromatographic elution of both
compounds was also investigated by changes in the pH values
of the aqueous component of the mobile phase from 2.5 to 7.0.
For all experimental concentration values, the drugs are eluted
in order of PPZ and LPZ. A concentration value of 0.1 M
NH4OAC was chosen for the optimum separation of the com-
pounds, as at this concentration the analyte peaks were well
deﬁned and resolved. The optimum wavelength for detectionTable 2 Accuracy and precision of within and between run analysi
Nominal concentration (lg mL1) Assayed concentration (lg
Mean ± SD
Intra-day (n = 14)
3.06 3.07 ± 0.06
10.00 10.03 ± 0.14
100.00 103.95 ± 1.11
200.00 203.51 ± 1.95
400.00 402.10 ± 2.93
800.00 800.04 ± 4.64
1200.00 1202.65 ± 4.33
Inter-day (n = 14)
3.06 3.10 ± 0.06
10.00 9.98 ± 0.16
100.00 102.97 ± 1.07
200.00 198.14 ± 1.68
400.00 402.54 ± 2.45
800.00 802.77 ± 4.01
1200.00 1194.33 ± 5.02was at 280 nm, at which the best detector responses for all sub-
stances were obtained. The speciﬁcity of the HPLC method is
illustrated in Fig. 2 where complete separation of the com-
pounds was observed. PPZ was eluted at 8.10 min, while the
internal standard LPZ was eluted at 11.15 min.
3.2. Linearity and limits of quantiﬁcation and detection
Standard curve of PPZ was linear (r2 > 0.99) over the concen-
tration range 3.06–1243.0 lg mL1. Straight line for PPZ was
obtained, when the area of the peaks were plotted vs. concen-
tration (Table 1). Also, Linear relationship was obtained be-
tween the peak area ratio of PPZ to that of the internals for the determination of pantoprazole by HPLC.
mL1)
RSD (%) Recovery (%) Relative error (%)
1.86 100.18 0.18
1.41 100.31 0.31
1.07 103.95 3.95
0.96 101.76 1.76
0.73 100.52 0.52
0.58 100.01 0.01
0.36 100.22 0.22
2.07 101.22 1.22
1.56 99.78 0.22
1.04 102.97 2.97
0.85 99.07 0.93
0.61 100.64 0.64
0.50 101.31 1.13
0.42 99.96 0.04
Table 3 Determination of PPZ in pharmaceutical formulations by the proposed method and ofﬁcial method.
Producta Pharmaceutical company
(country of origin)
%Foundb ± SD
Proposed method Oﬃcial method
Penta 40 mg Alpha (Syria) 102.23 ± 1.08 99.44 ± 1.02
t= 1.87 t= 1.92
F= 1.12
Progast 40 mg K.C. Pharma (Syria) 100.40 ± 0.78 100.70 ± 0.64
t= 1.43 t= 1.75
F= 1.48
Pantoprazol 40 mg Amrit Medical Co. (Syria) 104.83 ± 0.37 103.17 ± 0.31
t= 2.05 t= 2.25
F= 1.42
a The dose is 40 mg expressed as pantoprazole sodium for all products.
b Five independent analyses. At 95% conﬁdence level t-value is 2.776 and F-value is 6.26.
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(3.06–1243.0 lg mL1), as shown by the equations presented
in Table 1.
The minimum level at which the investigated compound
can be reliably detected (limit of detection, LOD) and quanti-
ﬁed (limit of quantitation, LOQ) were determined experimen-
tally. LOD was expressed as the concentration of drug that
generated a response to three times of the signal to-noise (S/
N) ratio, and LOQ was 10 times of the S/N ratio. The LOD
of PPZ attained as deﬁned by IUPAC (Long and Winefordner,
1983), LOD(k = 3) = k · Sa/b (where b is the slope of the cali-
bration curve and Sa is the standard deviation of the intercept),
was found to be 0.78 lg mL1. The LOQ was also attained
according to the IUPAC deﬁnition, LOQ(k = 10) = k · Sa/b,
and was found to be 2.60 lg mL1.
3.3. Accuracy and precision
The precision and accuracy of the method were evaluated by
intra- (analysis of standard solutions of PPZ in replicates of
ﬁve in the same day) and inter-day (analysis of standard solu-
tions of PPZ in replicates of ﬁve on three different days from
day 1 to 30 after preparation) assay variance (Table 2). The
standard deviation, relative standard deviation, recovery and
relative percentage error of different amounts tested were
determined, as recorded in Table 2. The accuracy of the meth-
od is indicated by the excellent recovery (99.07–103.95%) and
the precision is supported by the low standard deviation. Table
2 shows that the percent error of the method was always less
than 3.95%; therefore, it was concluded that the procedure
gives acceptable accuracy and precision for the analyte.
3.4. Application of the assay
The present method has been successfully applied for the deter-
mination of pantoprazole sodium in three different pantopraz-
ole preparations. The resulted chromatogram has been shown
in Fig. 3. Student’s t-test was used for statistical analysis of the
data and statistical signiﬁcance was deﬁned at the level of P <
0.05. The results obtained with the proposed method were
compared with the ofﬁcial method (British Pharmacopœia,
2009) and have been shown in Table 3. Good agreement with
results obtained by the ofﬁcial method was observed. The
proposed method is simple, rapid, accurate, highly sensitiveand suitable for the routine quality control without interfer-
ence from the excipients and additives such as starch, glucose
and lactose.
4. Conclusion
The proposed analytical method was simple, rapid, accurate,
precise and inexpensive, because the lower solvent consump-
tion along with the short analytical run time of 12 min, and
hence can be used for the routine analysis of PPZ in bulk
and pharmaceutical formulations. The sample recoveries from
all formulations were in good agreement with their respective
label claims, which suggested non-interference of formulations
excipients in the estimation. Moreover, the present method is
fast with respect to analysis time as compared to sophisticated
chromatographic techniques. The method provided excellent
speciﬁcity and linearity with a limit of quantiﬁcation of
2.60 lg mL1 and limit of detection of 0.78 lg mL1. The
major advantage of this method is the wide range of linearity.
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